2023
DOI: 10.25259/sni_224_2023
|View full text |Cite
|
Sign up to set email alerts
|

Coil embolization for post-bypass aneurysm of middle meningeal artery for moyamoya disease – preservation of transdural anastomosis

Abstract: Background: Middle meningeal artery (MMA) pseudoaneurysm following revascularization surgery for moyamoya disease (MMD) is rare. Case Description: Here, a 29-year-old man presented with an MMA pseudoaneurysm after he underwent revascularization surgery (superficial temporal artery-to-middle cerebral artery bypass and encephalo-duro-myoarterio-pericranial synangiosis) for hemorrhagic MMD. At 3 months post-surgery, digital subtraction angiography showed a pseudoaneurysm in the right MMA. Transdural anastomos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Alternatively, hemostatic treatment or aneurysm embolization by endovascular therapy should be considered first if it is possible under the emergent situation. 15 )…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, hemostatic treatment or aneurysm embolization by endovascular therapy should be considered first if it is possible under the emergent situation. 15 )…”
Section: Discussionmentioning
confidence: 99%
“…As such, endovascular embolization is considered first-line treatment of pseudoaneurysms in the absence of significant mass effect [ 14 , 19 ]. Modalities can include liquid embolic agents such as Onyx [ 12 , 16 ] or N-butyl cyanoacrylate [ 6 , 11 , 13 ] as well as endovascular coiling [ 2 , 3 , 5 , 14 , 17 , 20 ]. A long-term follow-up is not well characterized with regard to the risk of recurrence or recanalization, thus no specific method of embolization can be recommended at this time.…”
Section: Discussionmentioning
confidence: 99%